The US healthcare industry is the largest in the world and accounts for a larger share of the gross national product than in any other major industrialized country. Faced with the challenge of ever increasing costs and competition, healthcare companies continually seek strategies to provide affordable services that benefit consumers and add value for shareholders. To offer comprehensive representation to our clients in the healthcare industry, Weil draws from its Corporate, Litigation, Business Finance & Restructuring and Tax practices.

We litigate and counsel clients on a wide range of issues affecting the health care industry.  We have litigated cases establishing important precedents in the nation’s highest court and in cases with industry-wide impact.  We have successfully defended major health insurers in a wide variety of class actions where we have either defeated the class or won on summary judgment.  We represent corporations and individuals in the health care industry in investigations and criminal, regulatory and civil proceedings by governmental authorities and qui tam plaintiffs.  We have in-depth expertise in antitrust issues in the healthcare industry from our unique combination of public and private enforcement experience.  Our experience spans a broad range of transactional, counseling and litigation matters and virtually every conceivable antitrust issue involving stakeholders throughout the healthcare system, including PBMs and retail distribution, health care insurers and other managed care payers and physician and hospital providers.  Our record is exceptional – both for obtaining efficient merger clearance of complex, multinational transactions and for successfully resolving government investigations and private antitrust litigation.The effort to contain rising costs and maintain services has led healthcare companies to seek partners to enhance their own businesses. Weil’s Corporate and Antitrust practices have represented major providers in structuring these transactions and in obtaining regulatory approvals from the Federal Trade Commission, US Department of Justice and from state regulatory agencies.

Additionally, the pursuit of joint ventures is accompanied by a host of legal issues for healthcare providers and research companies. Weil has provided counsel for clients involved in every type of investment, purchase and sale of healthcare entities, drawing on our experience in private equity, antitrust, licensing, tax, patent litigation and counseling and intellectual property.

The growing demand for services and increased competition can lead to opportunity or to a squeeze on profitability. In recent years, several healthcare providers have faced restructuring and insolvency. As a leading healthcare restructuring group, Weil has experience with all major types of healthcare organizations. By employing a multidisciplinary approach, our Corporate, M&A, Litigation, Global Dispute Resolution and Business Finance & Restructuring practices assist healthcare organizations in returning to profitability and maintaining the services they provide to their patients.